Lilly Asia Ventures

Founded in 2008, Lilly Asia Ventures (LAV) is a biomedical venture capital firm that manages over $4.5 billion in committed capital. With offices in Shanghai, Hong Kong, and Palo Alto, LAV's strategy combines its China expertise and global perspectives to support its portfolio companies and investors worldwide.
Firm Website

Lilly Asia Ventures Profile

All Strategies:
Headquarters: Shanghai, China
Lilly Asia Ventures Email Format: (first).(last)@lavfund.com
BETA - firm profiles early launch

Investor Type

Venture

LTM Investments

5

LTM Exits

1
Lilly Asia Ventures RETURNS BY FUND

Fund size displayed in millions; returns metrics are net of fees

Lilly Asia Ventures RECENT TRANSACTIONS
Lilly Asia Ventures RECENT EXITS

RELATED FIRMS

Join Transacted for Free

Sign up today for unlimited access to the latest private equity news, trends, and insights.

  • Always free
  • Exclusive stories written specifically for investors
  • The weekly briefing with news, deals, and fundraising activity
  • Firm profiles & transaction data for buyout and growth investors